Temporary Delayed Hypersensitivity Reaction to Botulinum Toxin-A After COVID-19 Vaccination: A Case Series
Aesthetic Plastic Surgery · 2024
DOI: 10.1007/s00266-024-04274-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Aesthetic Plastic Surgery, 2024. Verfasst von Fabio Daniel Padilla-Pantoja und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Universidad de Valladolid, Valladolid, Spain. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Hypersensitivity, Delayed, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The occurrence of a hypersensitivity reaction with the injection of botulinum toxin type A (BTX-A) in cosmetic use is a rare complication. We report the largest case series of temporary delayed hypersensitivity reaction (DHR) with BTX-A following COVID-19 vaccination and the first cases to incobotulinum toxin A (incoBTX-A). METHODS: A retrospective multicentric case series of patients who developed a DHR to BTX-A after COVID-19 vaccination. RESULTS: Twelve patients were treated with BTX-A injections for the management of facial rhytids. The age range was between 29 and 45 years. Ten (83.3%) were female. Ten (83.3%) patients received incoBTX-A, and two received onabotulinum toxin A (onaBTX-A). All patients had COVID-19 vaccination (mRNA vaccine) between 1 and 7 months before. Within an average time of 24 h after BTX-A injection, all patients developed progressive facial swelling and erythema that were more prominent at the injection points. Intradermal allergic tests to BTX-A were performed in six (50%) patients, and the results were all negative. Adequate clinical control was achieved with systemic corticosteroids and antihistamines. After 1 year with no further vaccination, a new BTX-A treatment (provocation test) was performed in all patients with no secondary effects. CONCLUSION: Previous COVID-19 vaccination and the absence of new adverse events with further BTX-A injections suggest a temporary DHR. Clinicians should be aware of the importance of immunization history and its potential post-vaccine immunogenic effects with BTX-A. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, Universidad de Valladolid, Valladolid, Spain.
- Department of Facial Plastic & Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.
- Department of Ophthalmology, Hospital CUF Porto, Porto, Portugal.
- Department of Ophthalmology, Hospital Universitario Rio Hortega, C/Dulzaina 2, 47012, Valladolid, Spain. ali_galindo@yahoo.es.
ORCID-Profile: Alicia Galindo-Ferreiro
Zitieren
APA
Padilla-Pantoja, F. D., Fakih-Gomez, N., Muñoz-Gonzalez, C., Prazeres, S., & Galindo-Ferreiro, A. (2024). Temporary Delayed Hypersensitivity Reaction to Botulinum Toxin-A After COVID-19 Vaccination: A Case Series. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-024-04274-w
Vancouver
Padilla-Pantoja FD, Fakih-Gomez N, Muñoz-Gonzalez C, Prazeres S, Galindo-Ferreiro A. Temporary Delayed Hypersensitivity Reaction to Botulinum Toxin-A After COVID-19 Vaccination: A Case Series. Aesthetic Plastic Surgery. 2024. doi:10.1007/s00266-024-04274-w
BibTeX
@article{PadillaPantoja2024,
author = {Padilla-Pantoja, Fabio Daniel and Fakih-Gomez, Nabil and Muñoz-Gonzalez, Cristina and Prazeres, Sandra and Galindo-Ferreiro, Alicia},
title = {Temporary Delayed Hypersensitivity Reaction to Botulinum Toxin-A After COVID-19 Vaccination: A Case Series},
journal = {Aesthetic Plastic Surgery},
year = {2024},
doi = {10.1007/s00266-024-04274-w}
}
EUVIMED